日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

(191)Pt-labeled trithiol-Hoechst-PSMA: preliminary evaluation of conjugates designed for delivery to genomic DNA of PSMA-positive cancers

(191)Pt标记的三硫醇-Hoechst-PSMA:用于递送至PSMA阳性癌症基因组DNA的缀合物的初步评估

Obata, Honoka; Tsuji, Atsushi B; Feng, Yutian; Zheng, Yongxiang; Sugyo, Aya; Sudo, Hitomi; Kajiwara, Chie; Minegishi, Katsuyuki; Zhang, Ming-Rong; Zalutsky, Michael R

Longitudinal Imaging Reveals Tumor Uptake and Prolonged Retention of Bispecific T Cell-Engaging Antibody in GBM via Passive and Active Mechanisms.

纵向成像揭示了双特异性 T 细胞结合抗体在胶质母细胞瘤中通过被动和主动机制被肿瘤吸收和长期保留

Feng Yutian, Haupt Benedikt, Huynh Truc T, Meshaw Rebecca, Martin-Regalado Angela, Thakur Aditi, Duffy Joseph T, Alzeer Abdulaziz, Siegel David A, Barnes Ashlynn, Simberg Dmitri, Zalutsky Michael R, Balyasnikova Irina V

Enhancing the therapeutic index of [(211)At]YF2 with iodo pseudo carrier: A simple strategy for reducing accumulation in kidneys, salivary and lacrimal glands

利用碘化物假载体提高[(211)At]YF2的治疗指数:一种减少其在肾脏、唾液腺和泪腺中蓄积的简便策略

Huynh, Truc T; Feng, Yutian; Banks, Rebecca L; Vaidyanathan, Ganesan; Zalutsky, Michael R

A third generation PSMA-targeted agent [(211)At]YF2: Synthesis and in vivo evaluation

第三代PSMA靶向药物[(211)At]YF2:合成及体内评价

Feng, Yutian; Meshaw, Rebecca L; Finch, Sean W; Zheng, Yongxiang; Minn, Il; Vaidyanathan, Ganesan; Pomper, Martin G; Zalutsky, Michael R

DNA Repair Inhibitors: Potential Targets and Partners for Targeted Radionuclide Therapy

DNA修复抑制剂:靶向放射性核素治疗的潜在靶点和合作伙伴

Obata, Honoka; Ogawa, Mikako; Zalutsky, Michael R

Brachytherapy via a depot of biopolymer-bound 131I synergizes with nanoparticle paclitaxel in therapy-resistant pancreatic tumours

通过生物聚合物结合 131I 库进行近距离放射治疗与纳米颗粒紫杉醇协同作用,治疗难治性胰腺肿瘤

Jeffrey L Schaal, Jayanta Bhattacharyya, Jeremy Brownstein, Kyle C Strickland, Garrett Kelly, Soumen Saha, Joshua Milligan, Samagya Banskota, Xinghai Li, Wenge Liu, David G Kirsch, Michael R Zalutsky, Ashutosh Chilkoti

Planning and Implementing Strategically: Year 1 of the NINDS 2021-2026 Strategic Plan

战略规划与实施:NINDS 2021-2026 年战略计划第一年

Schor, Nina F; Scott, Paul; Litvina, Elizabeth Y; Torborg, Christine; Kim, Jenny L; Zalutsky, Robert; Adams, Amy Bany

Site-Specific Radiohalogenation of a HER2-Targeted Single-Domain Antibody Fragment Using a Novel Residualizing Prosthetic Agent

使用新型残基修复剂对 HER2 靶向单域抗体片段进行位点特异性放射性卤化

Yutian Feng, Samantha M Sarrett, Rebecca L Meshaw, Ganesan Vaidyanathan, Mike A Cornejo, Brian M Zeglis, Michael R Zalutsky

Low-level whole-brain radiation enhances theranostic potential of single-domain antibody fragments for human epidermal growth factor receptor type 2 (HER2)-positive brain metastases

低剂量全脑放射治疗可增强单域抗体片段对人表皮生长因子受体2型(HER2)阳性脑转移瘤的诊疗潜力

Procissi, Daniele; Jannetti, Stephen A; Zannikou, Markella; Zhou, Zhengyuan; McDougald, Darryl; Kanojia, Deepak; Zhang, Hui; Burdett, Kirsten; Vaidyanathan, Ganesan; Zalutsky, Michael R; Balyasnikova, Irina V

Evaluation of an 131I-labeled HER2-specific single domain antibody fragment for the radiopharmaceutical therapy of HER2-expressing cancers

评估 131I 标记的 HER2 特异性单域抗体片段对 HER2 表达癌症的放射性药物治疗

Yutian Feng, Rebecca Meshaw, Darryl McDougald, Zhengyuan Zhou, Xiao-Guang Zhao, Stephen A Jannetti, Robert E Reiman, Erica Pippen, Robin Marjoram, Jeffrey L Schaal, Ganesan Vaidyanathan, Michael R Zalutsky